Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares
BEIJING--(BUSINESS WIRE)--Mar 8, 2019--Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today issued an up…
